Multiorgan fibrosis in Gaucher disease type I: an unmet goal of enzyme replacement therapy

Keyphrases

• Bone Disease 25%
• Bone Marrow Biopsy 25%
• Bone Marrow Fibrosis 50%
• Cirrhosis 25%
• Cytopenia 50%
• Disease Complications 25%
• Early Detection 25%
• Early Management 25%
• Enzyme Replacement Therapy 100%
• Fibroscan 25%
• Fibrosis 100%
• Fibrosis Severity 25%
• Fibrotic Progression 25%
• Gaucher Disease 100%
• Glucocerebroside 25%
• Hepatosplenomegaly 25%
• Liver 25%
• Liver Fibrosis 25%
• Liver Stiffness 50%
• Lysosomal Storage Disease 25%
• Macrophages 25%
• Multi-organ 100%
• Multisystem Involvement 25%
• Nave 50%
• Noninvasive Model 25%
• Organomegaly 25%
• Spleen Stiffness 50%
• Stiffness 25%
• Strong Correlation 25%
• Transient Elastography 25%
• Unmet 100%

Pharmacology, Toxicology and Pharmaceutical Science

• Bone Disease 16%
• Cytopenia 33%
• Diseases 16%
• Enzymes 100%
• Fibrosis 100%
• Gaucher Disease Type 1 100%
• Gaucher's Disease 16%
• Glucosylceramide 16%
• Hepatosplenomegaly 16%
• Liver Cirrhosis 16%
• Liver Fibrosis 16%
• Lysosome Storage Disease 16%
• Myelofibrosis 33%
• Prevalence 16%
• Replacement Therapy 100%
• Storage Disease 16%

Medicine and Dentistry

• Bone Disease 16%
• Bone Marrow Biopsy 16%
• Cytopenia 33%
• Diseases 16%
• Enzyme Replacement Therapy 100%
• FibroScan 16%
• Fibrosis 100%
• Gaucher Disease Type 1 100%
• Gaucher's Disease 16%
• Glucosylceramide 16%
• Hepatosplenomegaly 16%
• Liver Cirrhosis 16%
• Liver Fibrosis 16%
• Lysosomal Storage Disease 16%
• Macrophage 16%
• Myelofibrosis 33%
• Organomegaly 16%
• Prevalence 16%
• Storage Disease 16%
• Transient Elastography 16%